In this issue:
FENopta: fenebrutinib in relapsing MS
DMTs in late-onset vs. adult-onset RRMS
KFLC index as a biomarker in MS
Retinal OCT as a prognostic tool in MS
Recreational cannabis use & cognitive performance in MS
An AI-driven MS classification system
Spinal cord + brain MRI to detect active disease in non-relapsing progressive MS
Real-life use of 7 Tesla MRI in MS
BMI & ofatumumab response
Serum NfL to identify disease activity after DMT discontinuation
Please login below to download this issue (PDF)